CHRISTINA WILSON: Open Payments
NPI 1679939276 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,200 in 40 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $719 · 2025 $1,200
Food & beverage: $1,200
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $326 |
| AstraZeneca Pharmaceuticals LP | 7 | $190 |
| GlaxoSmithKline, LLC. | 6 | $184 |
| Merck Sharp & Dohme LLC | 5 | $135 |
| Eisai Inc. | 5 | $126 |
| Novartis Pharmaceuticals Corporation | 2 | $60 |
| Caris MPI, Inc. | 2 | $54 |
| Daiichi Sankyo Inc. | 2 | $51 |
| Verastem, Inc. | 1 | $31 |
| PFIZER INC. | 1 | $26 |
Products named: ELAHERE, LYNPARZA, JEMPERLI, Lenvima, KEYTRUDA, KISQALI, MI CANCER SEEK, Enhertu.
Industry payments across AL — which companies pay providers there.
